Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

165 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Results of the NRG Oncology/RTOG 0848 Adjuvant Chemotherapy Question-Erlotinib+Gemcitabine for Resected Cancer of the Pancreatic Head: A Phase II Randomized Clinical Trial.
Abrams RA, Winter KA, Safran H, Goodman KA, Regine WF, Berger AC, Gillin MT, Philip PA, Lowy AM, Wu A, DiPetrillo TA, Corn BW, Seaward SA, Haddock MG, Song S, Jiang Y, Fisher BJ, Katz AW, Mehta S, Willett CG, Crane CH. Abrams RA, et al. Among authors: safran h. Am J Clin Oncol. 2020 Mar;43(3):173-179. doi: 10.1097/COC.0000000000000633. Am J Clin Oncol. 2020. PMID: 31985516 Free PMC article. Clinical Trial.
Paclitaxel and concurrent radiation for locally advanced pancreatic cancer.
Safran H, Moore T, Iannitti D, Dipetrillo T, Akerman P, Cioffi W, Harrington D, Quirk D, Rathore R, Cruff D, Vakharia J, Vora S, Savarese D, Wanebo H. Safran H, et al. Int J Radiat Oncol Biol Phys. 2001 Apr 1;49(5):1275-9. doi: 10.1016/s0360-3016(00)01527-3. Int J Radiat Oncol Biol Phys. 2001. PMID: 11286834 Clinical Trial.
Overexpression of the HER-2/neu oncogene in pancreatic adenocarcinoma.
Safran H, Steinhoff M, Mangray S, Rathore R, King TC, Chai L, Berzein K, Moore T, Iannitti D, Reiss P, Pasquariello T, Akerman P, Quirk D, Mass R, Goldstein L, Tantravahi U. Safran H, et al. Am J Clin Oncol. 2001 Oct;24(5):496-9. doi: 10.1097/00000421-200110000-00016. Am J Clin Oncol. 2001. PMID: 11586103
Clinical research in pancreatic cancer: the Radiation Therapy Oncology Group trials.
Willett CG, Safran H, Abrams RA, Regine WF, Rich TA; Gastrointestinal Committee of the Radiation Therapy Oncology Group. Willett CG, et al. Among authors: safran h. Int J Radiat Oncol Biol Phys. 2003;56(4 Suppl):31-7. doi: 10.1016/s0360-3016(03)00446-2. Int J Radiat Oncol Biol Phys. 2003. PMID: 12826249 Review.
Phase III trial of gemcitabine plus tipifarnib compared with gemcitabine plus placebo in advanced pancreatic cancer.
Van Cutsem E, van de Velde H, Karasek P, Oettle H, Vervenne WL, Szawlowski A, Schoffski P, Post S, Verslype C, Neumann H, Safran H, Humblet Y, Perez Ruixo J, Ma Y, Von Hoff D. Van Cutsem E, et al. Among authors: safran h. J Clin Oncol. 2004 Apr 15;22(8):1430-8. doi: 10.1200/JCO.2004.10.112. J Clin Oncol. 2004. PMID: 15084616 Clinical Trial.
165 results